Tracer library / [111In]In-labeled NZ-16

[111In]In-labeled NZ-16

Also written as [111In]In-labeled NZ-16

Radionuclide: In-111
Modality: —
Production route: —
Stage: Preclinical
Syntheses indexed: 0

Dosimetry and biodistribution studies

What it is

Compound class: Monoclonal antibody (anti-podoplanin)
Target / mechanism: Podoplanin (PDPN) PMID 34685483
Clinical application: Malignant mesothelioma PMID 34685483
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [111In]In-labeled NZ-16, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 34685483, 41566839. Stage set/updated at stage 39 from PMID 34685483: 'This study aimed to evaluate the potential alpha-radioimmunotherapy (RIT) with a newly developed anti-PDPN antibody, NZ-16, compared with a previous antibody, NZ-12.'.